The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
Jeff Szer, Daniel J. Weisdorf, Sergio Querol, Lydia Foeken, J. Alejandro Madrigal
Topics & Concepts
Collateral damageMedicineCoronavirus disease 2019 (COVID-19)Stem cellHaematopoiesis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Hematopoietic stem cellHematopoietic cellImmunologyVirologyInternal medicineGeneticsDiseaseBiologyOutbreakInfectious disease (medical specialty)SociologyCriminologyCOVID-19 and healthcare impactsBiomedical Ethics and RegulationImmune responses and vaccinations